Direct-To-Consumer Sales Can Fulfill Trump’s Drug Pricing Promises

Horizontal,Image,Of,A,Box,Of,Compounded,Prescription,Medications,Shipped

What actually works is what has always worked: markets, competition, and transparency. The polling on DTC programs proves voters understand this instinctively. And the White House would be wise to push DTC programs as a way to lower costs while keeping America the world’s medicine chest.

The Trump administration wants to enable more Americans to purchase prescription medications directly from manufacturers at transparent, discounted prices—thus collectively saving patients tens of billions of dollars by cutting out middlemen in the drug supply chain.

Voters overwhelmingly like the president’s idea. In a recent poll, 90% of Republican voters in congressional battleground districts, along with 85% of Democrats and 82% of independents, said they support these “direct-to-consumer” sales.

Read the op-ed here.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top